Sonja Sharpe
GlaxoSmithKline
Director, Technology Development, Advanced Manufacturing Technologies
Sonja leads a global team responsible for developing novel secondary (drug product) manufacturing technologies with the goal of streamlining and simplifying drug product process development and manufacturing. She has over 11 years of experience in the area of process engineering and technology development for both primary and secondary processes, with particular expertise in the design, optimization, and control of the API particle forming step, including formulation and particle engineering.